Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
Abstract Necroptosis, a regulated form of necrosis, has emerged as a novel therapeutic strategy that could enhance cancer immunotherapy. However, its role in tumorigenesis is still debated because recent studies have reported both anti- and pro-tumoral effects. Here, we aimed to systematically evalu...
Enregistré dans:
Auteurs principaux: | Thanpisit Lomphithak, Perawatt Akara-amornthum, Keigo Murakami, Masatoshi Hashimoto, Hajime Usubuchi, Erina Iwabuchi, Michiaki Unno, Zhenyu Cai, Hironobu Sasano, Siriporn Jitkaew |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bed78c056bbb47fc9e8f4e47465203de |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer
par: Jin Young Baik, et autres
Publié: (2021) -
BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma
par: Keiichi Tamai, et autres
Publié: (2020) -
Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases
par: Qingfei Chu, et autres
Publié: (2021) -
Dysbiosis in the Human Microbiome of Cholangiocarcinoma
par: Benchen Rao, et autres
Publié: (2021) -
Vascular Resection in Perihilar Cholangiocarcinoma
par: Alejandro Serrablo, et autres
Publié: (2021)